Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/24/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 07/09/24
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 12/07/23
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 07/31/24
End: 03/31/25
Due: 03/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy | NCT05542576 | Amydis Inc. | user2@example.com | None | 2022-08-24 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| A Study of AMDX-2011P in Participants With CAA | NCT05709314 | Amydis Inc. | user2@example.com | None | 2024-07-09 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |
| A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma | NCT06223048 | Amydis Inc. | user2@example.com | None | 2023-12-07 | 2025-02-28 | 2026-02-28 | - | - | 2025-07-14 |
| A Study of AMDX-2011P in Participants With Alzheimer's Disease | NCT06514001 | Amydis Inc. | user2@example.com | None | 2024-07-31 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |